Comprehensive report on Greek pharmaceutical sector

A report from the trade group representing the Greek pharmaceutical sector reviews the impact of the country’s recent recession and provides an overview of the current state of play in the industry.

The document, produced by the Hellenic Association of Pharmaceutical Companies (SFEE), finds that total health expenditure decreased by 32.4% during the period 2010 to 2016, as public spending in Greece was tightened due to the ongoing fallout from the global financial crisis of 2008.

Estimates put total pharmaceutical expenditure in Greece at about 4.5 billion euros ($5.5 billion). About 760 million euros of this comes from in-patient care, and due to budgetary changes, this is expected to drop significantly, to 530 million euros this year.